LINC01229

Across TCGA pan-cancer cohorts, LINC01229 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated LINC01229 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher LINC01229 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC01229 expression acts as an unfavorable survival marker, although some lineages such as HNSC and BLCA show a favorable association.

HNSC, BLCA, and SKCM are the cancer types where LINC01229 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.459	0.304	<.001	64	view →
BLCA	OS	Tertile	II,III,IV	0.685	0.561	.008	60	view →
SKCM	OS	Tertile	All	0.492	0.245	.001	50	view →
LUAD	DFS	Quartile	III,IV	0.790	0.333	<.001	44	view →
LGG	OS	Tertile	All	0.368	0.559	<.001	39	view →
MESO	OS	Median	III,IV	0.794	0.291	.001	32	view →
ESCA	OS	Quartile	III,IV	0.751	0.313	.006	17	view →
UVM	OS	Median	All	0.743	0.500	.020	14	view →
KIRP	DFS	Median	All	0.957	0.863	.001	14	view →
CESC	OS	Median	II,III,IV	0.910	0.742	.014	14	view →
KIRC	DFS	Median	All	0.894	0.849	.022	8	view →
CHOL	DFS	Quartile	All	1.000	0.129	.014	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

LINC01229–HNSC (OS)

Open the HNSC breakdown →